Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CYSB2400105	人凝血因子Ⅸ	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2024-05-08		Sichuan Yuanda Shuyang Pharmaceutical Co Ltd			view
CYSB2400043	人凝血因子Ⅸ	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products(原7)	Supplementary Application	2024-02-20		Shandong Taibang Biological Products Co Ltd			view
CXSL2400072	人凝血因子IX	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products(3.4)	New Drug Application	2024-01-31		Chengdu Rongsheng Pharmaceuticals Co Ltd			view
CXSL2300595	人凝血因子IX	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products(3.4)	New Drug Application	2023-09-02		Hualan Biological Engineering Inc			view
CXSL2300529	人凝血因子IX	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products(3.4)	New Drug Application	2023-08-01		Guangdong Shuanglin Bio-Pharmacy Co Ltd			view
CYSB2300147	人凝血因子Ⅸ	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2023-07-28		Shandong Taibang Biological Products Co Ltd			view
CYSB2300115	人凝血因子Ⅸ	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products(原7)	Supplementary Application	2023-06-14		Shandong Taibang Biological Products Co Ltd			view
JYSZ2200036	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	License Renew	2022-07-21					view
JYSZ2200034	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	License Renew	2022-07-21					view
JYSZ2200033	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	License Renew	2022-07-21					view
JYSZ2200035	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	License Renew	2022-07-21					view
JYSB2101100	注射用重组人凝血因子IX	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-08-10					view
JYSB2101101	注射用重组人凝血因子IX	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-08-10					view
JYSB2101102	注射用重组人凝血因子IX	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-08-10					view
JYSB2101103	注射用重组人凝血因子IX	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-08-10					view
JYSB2100048	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-02-19			In Review	2021-02-18	view
JYSB2100047	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-02-19			In Review	2021-02-18	view
JYSB2100046	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-02-19			In Review	2021-02-18	view
JYSB2100045	注射用重组人凝血因子Ⅸ	Recombinant Coagulation Factor Ⅸ	Lyophilized	Biological Products	Supplementary Application	2021-02-19			In Review	2021-02-18	view
CYSB2100054	人凝血因子Ⅸ	Human Coagulation Factor Ⅸ	Lyophilized	Biological Products(原7)	Supplementary Application	2021-02-05	山东泰邦生物制品有限公司	Shandong Taibang Biological Products Co Ltd	In Review	2022-01-25	view